Join the Kloxxado group to help and get support from people like you.
Kloxxado News (Page 2)
More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder
FRIDAY, July 12, 2024 – Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28...
Trained Peers as Good as Social Workers at Preventing Opioid Overdoses
THURSDAY, July 11, 2024 – Support provided by someone who has personally lived with addiction is an effective way to follow-up with ER patients after an opioid overdose, new research shows. Patients...
New Drug Could Boost Lifesaving Powers of Overdose Drug Naloxone
MONDAY, July 8, 2024 – An experimental drug can supercharge the effects of the lifesaving overdose drug naloxone, potentially improving its effectiveness against new and more powerful opioids like...
Most Americans Don't Know That Family Doctors Can Prescribe Anti-Opioid Meds
TUESDAY, July 2, 2024 – Most people addicted to opioids and their loved ones are unaware that their primary care doctor can prescribe a medication to treat the disorder, a new nationwide survey...
Most Outpatient Mental Health Clinics Don't Offer Opioid Addiction Meds
WEDNESDAY, June 19, 2024 – Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with...
High Out-of-Pocket Costs Keep Some From Lifesaving Opioid Antidote
TUESDAY, June 18, 2024 – Patients are less likely to fill prescriptions for the overdose-reversing drug naloxone when they have to shell out more at the pharmacy, a new study finds. Naloxone (also...
Racial Disparity Seen in Naloxone Administration
FRIDAY, May 31, 2024 – In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic people, according to...
FDA Approves Kloxxado (naloxone hydrochloride) Nasal Spray for Emergency Treatment of Opioid Overdose
LONDON, April 30, 2021 /PRNewswire/ – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the approval of Kloxxado (naloxone hydrochloride) nasal spray 8mg, by the...